Genexys BioMed
Biotechnology Research • 
Cincinnati, Ohio, United States • 1-10 Employees
Company overview
| Headquarters | Cincinnati, Ohio, United States |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
Key Contact at Genexys BioMed
Ryan Fox
CEO at Genexys BioMed
About Genexys BioMed
A subsidiary of Orange Grove Bio, Genexys BioMed is at the forefront of next-generation genetic medicines, transforming treatment for cystic fibrosis (CF) and other genetic diseases. Powered by cutting-edge research from Cincinnati Children’s Hospital Medical Center, we are developing a non-viral, non-lipid nanoparticle platform designed for safe, durable, and re-dosable gene therapies.
Genexys BioMed revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Genexys BioMed has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Genexys BioMed has never raised funding before.
Spain
Germany
United Kingdom
United Arab Emirates
CanadaFrequently asked questions
4.8
40,000 users
